Excellence is just the beginning.


French German Italian Portuguese Russian

Treatment Study for Patients with Complex Regional Pain Syndrome

Clinical Trial Title: 
Open-label safety study of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS).
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Timothy R. Lubenow, MD
Clinical Trial Protocol Description: 

The purpose of this study is to study an investigational drug, neridronic acid, to test its safety in subjects with complex regional pain syndrome.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have CRPS.

You will be excluded from the study if any of the following criteria apply to you:

  • Have renal disease.
  • Have denture related gum trauma.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Pain Management
Contact Phone: 
(312) 942-2985
Contact Name: 
Sherry Robison, MBA